Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
TALK · against 491 other Healthcare companies of similar size
Ranked #308 of 492 · scores higher than 36% of peers
Bars: peers in each 10-point band of the valuation score30 peers with a valuation score of 30–39, including TALK · Click a bar to see the companies
Mainly because of its EBITDA yield, which is weaker than most Healthcare peers.
| Metric | TALK | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 480 reported | -0.2% | 1.1% | 43% | 30% | |
| EBITDA yieldHigher is better · 498 reported | 1.0% | 4.0% | 37% | 50% | |
| Free cash flow yieldHigher is better · 209 reported | 0.5% | -2.7% | 65% | 20% | |
| Book yieldHigher is better · 488 reported | 12.9% | 42.0% | 13% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 1 | 12.9B HKD (≈$1.7B) | 99 | 83 | |
| 1 | 89.9B JPY (≈$611M) | 99 | 68 | |
| 1 | 226.3B JPY (≈$1.5B) | 99 | 77 | |
| 1 | 14.8B MXN (≈$800M) | 99 | 61 | |
| 308 | 6.0B CNY (≈$840M) | 32 | 45 | |
| 308 | 1.1B USD | 32 | 61 | |
| 308 | 1.9B NZD (≈$1.1B) | 32 | 42 | |
| 308 | 1.5B EUR (≈$1.6B) | 32 | 44 | |
| 308 | 871M USD | 32 | 53 | |
| 317 | 2.21T KRW (≈$1.6B) | 30 | 57 | |
| 317 | 3.6B CNY (≈$507M) | 30 | 29 | |
| 317 | 2.6B AUD (≈$1.7B) | 30 | 62 | |
| 317 | 42.8B INR (≈$513M) | 30 | 37 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score